Delaware
|
1-14368
|
13-5630895
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
5430
LBJ Freeway, Suite 1700, Dallas, Texas
|
75240-2697
|
||
(Address
of principal executive offices)
|
(Zip
Code)
|
(Former
name or former address, if changed since last report.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers
|
· |
Dr.
Entrekin's employment as president and chief operating officer of
the
registrant effective January 1,
2007;
|
· |
an
initial term of two years, which can be extended for three additional
one
year terms;
|
· |
an
initial base salary for Dr. Entrekin of $550,000, with increases
to such
base salary from time to time in the registrant's
discretion;
|
· |
a
one-time payment of $250,000 to Dr. Entrekin on March 30,
2007;
|
· |
the
ability of Dr. Entrekin to participate in the registrant's Profit
Sharing
Plan, which for 2007 shall entitle him to receive 106% of his base
salary
and thereafter on the terms and conditions set by the registrant
under
such plan;
|
· |
the
receipt by Dr. Entrekin of service credit under certain benefit plans
for
the number of full years of service related to his prior employment
with
the registrant;
|
· |
a
severance payment of 12 months of base salary in the event of Dr.
Entrekin's termination "without cause" (as defined in the agreement),
non-renewal of the agreement on its fifth anniversary or upon a "change
in
control" of the Corporation (as defined in the agreement);
and
|
· |
certain
non-competition, non-interference, non-disclosure and proprietary
property
obligations of Dr. Entrekin.
|
· |
from
2003 to 2004 as managing director of London
& Scandinavian Metallurgical Co.
Ltd., a multi-location company engaged in primary and secondary metals
manufacturing; and
|
· |
from
September 2005 to December 2006, as president and chief executive
officer
of Timminco Ltd. (TSX: TIM), an international
producer and marketer of specialty magnesium, and engineered magnesium
extrusions, silicon metal and specialty ferrosilicon, calcium and
strontium alloys.
|
Titanium
Metals Corporation
|
|
(Registrant)
|
|
By: /s/
A. Andrew R. Louis
|
|
Date:
January 8, 2007
|
A.
Andrew R. Louis, Secretary
|